AKT1 and cancer: Typically, cancer cells sustain proliferative activity through the activation of the PI3K/AKT (phosphatidylinositol 3-kinase/protein kinase B, also PKB) or MAPK/ERK (mitogen-activated protein kinase/extracellular signal-regulated kinase) pathways.